bluuebunny/crossref_metadata_2025_split huggingface dataset:
Dosimetric study of 2D ion chamber array matrix for the modern radiotherapy treatment verification
Authors: Saminathan Sathiyan , Manickan Ravikumar , Chandraraj Varatharaj , Supe Sanjay. S. 
Published: February 2017

Intensity‐modulated radiotherapy treatment demands stringent quality assurance and accurate dose determination for delivery of highly conformal dose to the patients. Generally 3D dose distributions obtained from a treatment planning system have to be verified by dosimetric methods. Mainly, a comparison of two‐dimensional calculated and measured data in several coplanar planes is performed. In principle, there are many possibilities to measure two‐dimensional dose distributions such as films, flat‐panel electronic portal imaging devices (EPID), ion chambers and ionization chamber arrays, and radiographic and radiochromic films. The flat‐panel EPIDs show a good resolution and offer a possibility for real‐time measurements: however to convert the signal into dose, a separate commercial algorithm is required. The 2D ion chamber array system offers the real‐time measurements. In this study, dosimetric characteristics of 2D ion chamber array matrix were analyzed for verification of radiotherapy treatments. The dose linearity and dose rate effect of the I'matriXX device was studied using 6 MV, 18 MV photons and 12 MeV electrons. The output factor was estimated using I'matriXX device and compared with ion chamber measurements. The ion chamber array system was found to be linear in the dose range of 2–500 cGy and the response of the detector was found to be independent of dose rate between to . The estimated relative output factor with I'matriXX was found to match very well with the ion chamber measurements. To check the final dose delivered during IMRT planning, dose distribution patterns such as field‐in‐field, pyramidal, and chair tests were generated with the treatment planning system (TPS) and the same was executed in the accelerator and measured with the I'matriXX device. The dose distribution pattern measured by the matrix device for field‐in‐field, pyramidal, and chair test were found to be in good agreement with the calculated dose distribution by TPS both for 6 and 18 MV photons (γ ≤ 1: 96%, criteria 3%, 3 mm). Two 7‐field IMRT plans (one prostate, one head and neck) dose distribution patterns were also measured with I'matriXX device and compared with film dosimetry. The measurements and evaluation proves that I'matriXX can be used for quantifying absolute dose. Moreover, using I'matriXX as absolute dosimeter in IMRT field verification, avoids the time‐consuming procedure of making ionometric measurement for absolute dose estimation and film for dose distribution verification. The I'matriXX can also used for routine quality assurance checks like flatness, symmetry, field width, and penumbra of the linear accelerator beam.PACS number: 87.55.ne and 87.56.Fc
Commissioning of a double‐focused micro multileaf collimator (μMLC)
Authors: Fischer Marcus , Todorovic Manuel , Drud Eva , Cremers Florian 
Published: February 2017

Double‐focused μMLCs are able to create fields with steeper dose gradients at the field edges and are, therefore, an advancement in delivering stereotactic treatments. A double‐focused μMLC has been installed at a Siemens Primus linear accelerator (linac) as a first research installation in Europe. The basic dosimetric parameters, such as leakage, output factors, depth‐dose curves and penumbra, have been measured in 6 and 15 MV‐mode by use of radiochromic films (GafChromic EBT), ionization chambers and our solid water QA‐phantom (Easy Cube). The leakage between the leaves is minimal and lower than that of most commercially available MLCs. Therefore, the field size of the linac can be kept constant while the leaves of the μMLC are creating different aperture shapes. Percentage depth doses (PDDs) generated by the double‐focused μMLC are equal to depth‐dose curves of the original linac. That means the μMLC affects only the off‐axis ratio (OAR). Based on the fact that the μMLC is double‐focused and the source‐to‐collimator distance is larger, the penumbra is sharper than that for fields defined by the original linac MLC. The mechanical and dosimetric investigations show the benefit of the double‐focused μMLC attached to a Siemens Primus linear accelerator.PACS number: 87.10.+e
An organ and effective dose study of XVI and OBI cone‐beam CT systems
Authors: Hyer Daniel E. , Serago Christopher F. , Kim Siyong , Li Jonathan G. , Hintenlang David E. 
Published: February 2017

The main purpose of this work was to quantify patient organ doses from the two kilovoltage cone beam computed tomography (CBCT) systems currently available on medical linear accelerators, namely the X‐ray Volumetric Imager (XVI, Elekta Oncology Systems) and the On‐Board Imager (OBI, Varian Medical Systems). Organ dose measurements were performed using a fiber‐optic coupled (FOC) dosimetry system along with an adult male anthropomorphic phantom for three different clinically relevant scan sites: head, chest, and pelvis. The FOC dosimeter was previously characterized at diagnostic energies by Hyer et al. [Med Phys 2009;36(5):1711–16] and a total uncertainty of approximately 4% was found for in‐phantom dose measurements. All scans were performed using current manufacturer‐installed clinical protocols and appropriate bow‐tie filters. A comparison of image quality between these manufacturer‐installed protocols was also performed using a Catphan 440 image quality phantom. Results indicated that for the XVI, the dose to the lens of the eye (1.07 mGy) was highest in a head scan, thyroid dose (19.24 mGy) was highest in a chest scan, and gonad dose (29 mGy) was highest in a pelvis scan. For the OBI, brain dose (3.01 mGy) was highest in a head scan, breast dose (5.34 mGy) was highest in a chest scan, and gonad dose (34.61 mGy) was highest in a pelvis scan. Image quality measurements demonstrated that the OBI provided superior image quality for all protocols, with both better spatial resolution and low‐contrast detectability. The measured organ doses were also used to calculate a reference male effective dose to allow further comparison of the two machines and imaging protocols. The head, chest, and pelvis scans yielded effective doses of 0.04, 7.15, and 3.73 mSv for the XVI, and 0.12, 1.82, and 4.34 mSv for the OBI, respectively.PACS number: 87.57.uq
Quantification and reduction of peripheral dose from leakage radiation on Siemens primus accelerators in electron therapy mode
Authors: Yeboah Collins , Karotki Alex , Hunt Dylan , Holly Rick 
Published: February 2017

In this work, leakage radiation from EA200 series electron applicators on Siemens Primus accelerators is quantified, and its penetration ability in water and/or the shielding material Xenolite‐NL established. Initially, measurement of leakage from applicators was performed as a function of height along applicator and of lateral distance from applicator body. Relative to central‐axis ionization maximum in solid water, the maximum leakage in air observed with a cylindrical ion chamber with 1 cm solid water buildup cap at a lateral distance of 2 cm from the front and right sidewalls of applicators were 17% and 14%, respectively; these maxima were recorded for 18 MeV electron beams and applicator sizes of . In the patient plane, the applicator leakage gave rise to a broad peripheral dose off‐axis distance peak that shifted closer to the field edge as the electron energy increases. The maximum peripheral dose from normally incident primary electron beams at a depth of 1 cm in a water phantom was observed to be equal to 5% of the central‐axis dose maximum and as high as 9% for obliquely incident beams with angles of obliquity . Measured depth‐peripheral dose curves showed that the “practical range” of the leakage electrons in water varies from approximately 1.4 to 5.7 cm as the primary electron beam energy is raised from 6 to 18 MeV. Next, transmission measurements of leakage radiation through the shielding material Xenolite‐NL showed a 4 mm thick sheet of this material is required to attenuate the leakage from 9 MeV beams by two‐thirds, and that for every additional 3 MeV increase in the primary electron beam energy, an additional Xenolite‐NL thickness of roughly 2 mm is needed to achieve the aforementioned attenuation level. Finally, attachment of a 1 mm thick sheet of lead to the outer surface of applicator sidewalls resulted in a reduction of the peripheral dose by up to 80% and 74% for 9 and 18 MeV beams, respectively. This sidewall modification had an insignificant effect on the clinical depth dose, cross‐axis beam profiles, and output factors.PACS numbers: 87.53.Bn, 87.56.bd, 87.56.J‐
Analysis of peripheral doses for base of tongue treatment by linear accelerator and helical TomoTherapy IMRT
Authors: Bennett Brian Richard , Lamba Michael A. S. , Elson Howard R. 
Published: February 2017

The purpose of this study was to compare the peripheral doses to various organs from a typical head and neck intensity‐modulated radiation therapy (IMRT) treatment delivered by linear accelerator (linac) and helical TomoTherapy.Multiple human CT data sets were used to segment critical structures and organs at risk, fused and adjusted to an anthropomorphic phantom. Eighteen contours were designated for thermoluminescent dosimeter (TLD) placement. Following the RTOG IMRT Protocol 0522, treatment of the primary tumor and involved nodes (PTV70) and subclinical disease sites (PTV56) was planned utilizing IMRT to 70 Gy and 56 Gy. Clinically acceptable treatment plans were produced for linac and TomoTherapy treatments. TLDs were placed and each treatment plan was delivered to the anthropomorphic phantom four times.Within 2.5 cm (one helical TomoTherapy field width) superior and inferior to the field edges, normal tissue doses were on average 45% lower using linear accelerator. Beyond 2.5 cm, the helical TomoTherapy normal tissue dose was an average of 52% lower. The majority of points proved to be statistically different using the Student's t‐test with . Using one method of calculation, probability of a secondary malignancy was 5.88% for the linear accelerator and 4.08% for helical TomoTherapy.Helical TomoTherapy delivers more dose than a linac immediately above and below the treatment field, contributing to the higher peripheral doses adjacent to the field. At distances beyond one field width (where leakage is dominant), helical TomoTherapy doses are lower than linear accelerator doses.PACS number: 87.50.cm Dosimetry/exposure assessment
Assessment of a commercially available automatic deformable registration system
Authors: Fallone B. Gino , Rivest D. Ryan C. , Riauka Terence A. , Murtha Albert D. 
Published: February 2017

In recent years, a number of approaches have been applied to the problem of deformable registration validation. However, the challenge of assessing a commercial deformable registration system – in particular, an automatic registration system in which the deformable transformation is not readily accessible – has not been addressed. Using a collection of novel and established methods, we have developed a comprehensive, four‐component protocol for the validation of automatic deformable image registration systems over a range of IGRT applications. The protocol, which was applied to the Reveal‐MVS system, initially consists of a phantom study for determination of the system's general tendencies, while relative comparison of different registration settings is achieved through postregistration similarity measure evaluation. Synthetic transformations and contour‐based metrics are used for absolute verification of the system's intra‐modality and inter‐modality capabilities, respectively. Results suggest that the commercial system is more apt to account for global deformations than local variations when performing deformable image registration. Although the protocol was used to assess the capabilities of the Reveal‐MVS system, it can readily be applied to other commercial systems. The protocol is by no means static or definitive, and can be further expanded to investigate other potential deformable registration applications.PACS numbers: 87.19.xj, 87.56.Da, 87.57.nj
Evaluation of tumor motion effects on dose distribution for hypofractionated intensity‐modulated radiotherapy of non‐small‐cell lung cancer
Authors: Kang Hyejoo , Yorke Ellen D. , Yang Jie , Chui Chen‐Shou , Rosenzweig Kenneth E. , Amols Howard I. 
Published: February 2017

Respiration‐induced tumor motion during intensity‐modulated radiotherapy (IMRT) of non‐small‐cell lung cancer (NSCLC) could cause substantial differences between planned and delivered doses. While it has been shown that, for conventionally fractionated IMRT, motion effects average out over the course of many treatments, this might not be true for hypofractionated IMRT (IMHFRT). Numerical simulations were performed for nine NSCLC patients (11 tumors) to evaluate this problem. Dose distributions to the Clinical Target Volume (CTV) and Internal Target Volume (ITV) were retrospectively calculated using the previously‐calculated leaf motion files but with the addition of typical periodic motion (i.e. amplitude 0.36–1.26 cm, 3–8 sec period). A typical IMHFRT prescription of fractions was assumed. For the largest amplitude (1.26 cm), the average ± standard deviation of the ratio of simulated to planned mean dose, minimum dose, D95 and V95 were , , and for the CTV, and , , and for the ITV, respectively. There was minimal dependence on period or initial phase. For typical tumor geometries and respiratory amplitudes, changes in target coverage are minimal but can be significant for larger amplitudes, faster beam delivery, more highly‐modulated fields, and smaller field margins.PACS number: 87.55.dk
Shielding assessment of a mobile electron accelerator for intra‐operative radiotherapy
Authors: Krechetov Alexandre S. , Goer Donald , Dikeman Kate , Daves Jodi L. , Mills Michael D. 
Published: February 2017

The purpose of this investigation is to measure, characterize and report stray photon leakage and scatter radiation measurements from the Mobetron, an intra‐operative electron linear accelerator designed for use in an operating room environment. The study is needed due to recent changes to the shielding design of the Mobetron, and also to provide specific information that may be required by regulation in various jurisdictions. An analysis is performed on a number of manufactured units to determine an average 3D stray photon radiation map. This information provides a basis for determining patient‐based load restrictions and/or additional shielding for the operating room. The data presented evaluates the number of procedures for which the Mobetron may be safely operated in a typical unshielded operating room.PACS number: 87.53.‐j; 87.56.‐v
Analysis of variation in calibration curves for Kodak XV radiographic film using model‐based parameters
Authors: Hsu Shu‐Hui , Kulasekere Ravi , Roberson Peter L. 
Published: February 2017

Film calibration is time‐consuming work when dose accuracy is essential while working in a range of photon scatter environments. This study uses the single‐target single‐hit model of film response to fit the calibration curves as a function of calibration method, processor condition, field size and depth. Kodak XV film was irradiated perpendicular to the beam axis in a solid water phantom. Standard calibration films (one dose point per film) were irradiated at 90 cm source‐to‐surface distance (SSD) for various doses (16–128 cGy), depths (0.2, 0.5, 1.5, 5, 10 cm) and field sizes ( and ). The 8‐field calibration method (eight dose points per film) was used as a reference for each experiment, taken at 95 cm SSD and 5 cm depth. The delivered doses were measured using an Attix parallel plate chamber for improved accuracy of dose estimation in the buildup region. Three fitting methods with one to three dose points per calibration curve were investigated for the field sizes of and . The inter‐day variation of model parameters (background, saturation and slope) were 1.8%, 5.7%, and 7.7% (1 σ) using the 8‐field method. The saturation parameter ratio of standard to 8‐field curves was . The slope parameter ratio of standard to 8‐field curves ranged from 0.99 to 1.05, depending on field size and depth. The slope parameter ratio decreases with increasing depth below 0.5 cm for the three field sizes. It increases with increasing depths above 0.5 cm. A calibration curve with one to three dose points fitted with the model is possible with 2% accuracy in film dosimetry for various irradiation conditions. The proposed fitting methods may reduce workload while providing energy dependence correction in radiographic film dosimetry. This study is limited to radiographic XV film with a Lumisys scanner.PACS number: 87.55.Qr
Three‐dimensional dosimetry of TomoTherapy by MRI‐based polymer gel technique
Authors: Watanabe Yoichi , Gopishankar N. 
Published: February 2017

Verification of the dose calculation model and the software used for treatment planning is an important step for accurate radiation delivery in radiation therapy. Using BANG3 polymer gel dosimeter with a 3 Tesla magnetic resonance imaging (MRI) scanner, we examined the accuracy of TomoTherapy treatment planning and radiation delivery. We evaluated one prostate treatment case and found the calculated three‐dimensional (3D) dose distributions agree with the measured 3D dose distributions with an exception in the regions where the dose was much smaller (25% or less) than the maximum dose (2.5 Gy). The analysis using the gamma‐index (3% dose difference and 3 mm distance‐to‐agreement) for a volume of containing the planning target volume showed that the gamma values were smaller than unity for 53% of the voxels. Our measurement protocol and analysis tools can be easily applied to the evaluation of other newer complex radiation delivery techniques, such as intensity‐modulated arc therapy, with a reasonably low financial investment.PACS numbers: 87.53Bn, 87.56Fc
A RapidArc planning strategy for prostate with simultaneous integrated boost
Authors: Jolly David , Alahakone Dineli , Meyer Juergen 
Published: February 2017

Since the clinical implementation of novel rotational forms of intensity‐modulated radiotherapy, a variety of planning studies have been published that reinforce the major selling points of the technique. Namely, comparable or even improved dose distributions with a reduction in both monitor units and treatment times, when compared with static gantry intensity‐modulated radiotherapy. Although the data are promising, a rigorous approach to produce these plans has yet to be established. As a result, this study outlines a robust and streamlined planning strategy with a concentration on RapidArc class solutions for prostate with a simultaneous integrated boost. This planning strategy outlines the field setup, recommended starting objectives, required user interactions to be made throughout optimization and post‐optimization adjustments. A comparative planning study, with static gantry IMRT, is then presented as justification for the planning strategy itself. A variety of parameters are evaluated relating to both the planning itself (optimization and calculation time) and the plans that result. Results of this comparative study are in line with previously published data, and the planning process is streamlined to a point where the RapidArc optimization time takes minutes. Application of this planning strategy reduces the dependence of the produced plan on the experience of the planner, and has the potential to streamline the planning process within radiotherapy departments.PACS numbers: 87.55.x, 87.55.D, 87.55.de, 87.55.dk
Breast phantom with silicone implant for evaluation in conventional mammography
Authors: Silva Fábio A. R. , Souza Luíza F , Salmon Carlos E. G. , Souza Divanizia N 
Published: February 2017

With the increased incidence of cancer and a similarly increased number of surgeries for insertion of silicone breast implants, it is necessary to assess the effect of such material within the breast tissue, particularly in mammography, because of the reduction in the power of breast cancer diagnosis. In this work, we introduce a breast phantom with silicone implants in order to evaluate the influence of the implant on the visibility of the main mammographic findings: fibers, microcalcifications and tumor masses. In this proposed phantom, the breast tissue was simulated using gel paraffin. In the optical density of phantom mammograms with implants, a reduction in breast tissue visibility was seen corresponding to 23% when compared to a phantom without silicone implants. This poor visibility was due to the X‐ray beam scattering on silicone material; this effect produced a loss of visibility in the areas adjacent to the implant. It is expected that the proposed phantom model may be used as a device for the establishment of a technical standard for these types of procedures.PACS number: 87.59 E
Target localization accuracy in a respiratory phantom using BrainLab ExacTrac and 4DCT imaging
Authors: Matney Jason E. , Parker Brent C. , Neck Daniel W. , Henkelmann Greg , Rosen Isaac I. 
Published: February 2017

This study evaluated the accuracy of measuring the motion of an internal target using four‐dimensional computed tomography (4DCT) scanning and the BrainLAB ExacTrac X‐ray imaging system. Displacements of a metal coil implanted in a commercial respiratory phantom were measured in each system and compared to the known motion. A commercial respiratory motion phantom containing a metal coil as a surrogate target was used. Phantom longitudinal motions were sinusoidal with a 4.0 second period and amplitudes ranging from 5–25 mm. We acquired 4DCT and ExacTrac images of the coil at specified respiratory phases and recorded the coordinates of the coil ends. Coil displacement relative to the 0% phase (full‐inhale) position were computed for the ExacTrac and 4DCT imaging systems. Coil displacements were compared to known displacements based on the phantom's sinusoidal motion. Coil length distortion due to 4DCT phase binning was compared to the known physical length of the coil (31 mm). The maximum localization error for both coil endpoints for all motion settings was 3.5 mm for the 4DCT and 0.8 mm for the ExacTrac gating system. Coil length errors measured on the 4DCT were less than 0.8 mm at end inhale/exhale phases, but up to 8.3 mm at mid‐inhalation phases at the largest motion amplitude (25 mm). Due to the fast image acquisition time (100 ms), no coil distortion was observable in the ExacTrac system. 4DCT showed problems imaging the coil during mid‐respiratory phases of higher velocity (phases 20%–30% and 70%–80%) due to distortion caused by residual motion within the 4DCT phase bin. The ExacTrac imaging system was able to accurately localize the coil in the respiratory phantom over all phases of respiration. For our clinic, where end‐respiration phases from 4DCT may be used for treatment planning calculations, the ExacTrac system is used to measure internal target motion. With the ExacTrac system, planning target size and motion uncertainties are minimized, potentially reducing internal target volume margins in gated radiotherapy.PACS number: 87.56.‐v